Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00466024 · ClinicalTrials.gov registry record · Phase 3

Particulate Reduction Education in City Homes

A Phase 3 study, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 3
Development phase
125
Enrollment target

NCT00466024: Completed Phase 3 study, sponsored by Johns Hopkins University.

NCT00466024 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 125 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00466024, a Phase 3 study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 3
Development phase
125 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a randomized controlled trial of the efficacy of a combination of HEPA room air cleaners plus an ETS reduction behavior training as compared to either HEPA air cleaners plus standard asthma education or delayed HEPA air cleaners and standard asthma education (control group).

Interventions

  • BEHAVIORAL Health Coach and HEPA Air cleaners
  • BEHAVIORAL Health Coach and HEPA air cleaners

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2006-10
Est. Completion 2010-06
Phase Phase 3
Johns Hopkins University

1,448 total trials

What the finished NCT00466024 record still lists

NCT00466024 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Health Coach and HEPA Air cleaners is the first listed.

NCT00466024 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00466024 about?

NCT00466024 is a clinical study titled "Particulate Reduction Education in City Homes". The purpose of this study is to conduct a randomized controlled trial of the efficacy of a combination of HEPA room air cleaners plus an ETS reduction behavior training as compared to either HEPA air cleaners plus standard asthma education or delayed HEPA air cleaners and standard asthma education (...

What is the current status of trial NCT00466024?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 125 participants. The study started on 2006-10. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00466024?

The interventions under investigation include: Health Coach and HEPA Air cleaners (BEHAVIORAL), Health Coach and HEPA air cleaners (BEHAVIORAL).

Who is sponsoring clinical trial NCT00466024?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00466024's enrollment target sits among peer trials

125 1605th of 2000 higher than 391 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00466024, the US trial registry maintained by the National Library of Medicine. NCT00466024 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.